- Home
- PINC vs IMCR Comparison
PINC vs IMCR Comparison
Compare PINC & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PINC
- IMCR
- Stock Information
- Founded
- PINC 2013
- IMCR 2008
- Country
- PINC United States
- IMCR United Kingdom
- Employees
- PINC N/A
- IMCR N/A
- Industry
- PINC Other Consumer Services
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PINC Consumer Discretionary
- IMCR Health Care
- Exchange
- PINC Nasdaq
- IMCR Nasdaq
- Market Cap
- PINC 1.9B
- IMCR 1.7B
- IPO Year
- PINC 2013
- IMCR 2021
- Fundamental
- Price
- PINC $21.76
- IMCR $28.33
- Analyst Decision
- PINC Hold
- IMCR Buy
- Analyst Count
- PINC 7
- IMCR 13
- Target Price
- PINC $21.42
- IMCR $65.18
- AVG Volume (30 Days)
- PINC 1.0M
- IMCR 291.0K
- Earning Date
- PINC 02-03-2025
- IMCR 11-06-2024
- Dividend Yield
- PINC 3.86%
- IMCR N/A
- EPS Growth
- PINC N/A
- IMCR N/A
- EPS
- PINC 1.32
- IMCR N/A
- Revenue
- PINC $1,325,477,000.00
- IMCR $296,312,000.00
- Revenue This Year
- PINC N/A
- IMCR $29.19
- Revenue Next Year
- PINC $1.78
- IMCR $12.56
- P/E Ratio
- PINC $16.20
- IMCR N/A
- Revenue Growth
- PINC 2.65
- IMCR 25.09
- 52 Week Low
- PINC $17.96
- IMCR $27.69
- 52 Week High
- PINC $23.56
- IMCR $76.98
- Technical
- Relative Strength Index (RSI)
- PINC 49.19
- IMCR 31.28
- Support Level
- PINC $21.05
- IMCR $27.69
- Resistance Level
- PINC $21.95
- IMCR $29.91
- Average True Range (ATR)
- PINC 0.48
- IMCR 1.48
- MACD
- PINC -0.11
- IMCR -0.32
- Stochastic Oscillator
- PINC 43.96
- IMCR 11.45
About PINC Premier Inc.
Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.